1 August 1998‒31 July 2000, with tenure as of 1 August 2000
Translational cancer biology
University of Helsinki
Academy Professor Kari Alitalo heads the Academy-funded Centre of Excellence in Translational Cancer Biology at the University of Helsinki. Alitalo studies the functional genetics of cancer genes. A winner of several prestigious scientific awards, Alitalo is regarded as one of the world’s leading scientists in his field.
Alitalo’s research team is researching the role and function of cancer genes in intercellular communication and, in particular, different mechanisms underlying the onset of blood vessels in cancer. The team has identified several new growth factors, and, consequently, one of the practical aims of the research is to prevent malignant tumours from developing new vasculature and thereby to prevent the tumours from spreading. A separate Alitalo team working at the Wihuri Research Institute is investigating the role of lymphatic vessels in cardiovascular diseases, including obesity and associated inflammation and type 2 diabetes. The findings of this team are expected to lead to improved treatments for cancer, cardiovascular diseases and lymphatic diseases.
Alitalo maintains and develops an innovative, invigorating, internationally active and competitive research environment that supports the training of first-class independent researchers. A number of innovations produced under Alitalo’s supervision have already been patented and will be further developed into drug platforms.
Academy Professor Kari Alitalo is internationally one of Finland’s most recognised and most cited researchers.